1 邱海江,吴志明,等.AnnexinA2与恶性肿瘤的关系研究.肿瘤学杂志,2014,20:156-161.
2 陆秋涯,黄立东,陆佩华,等.AnnexinA2的结构和功能及其与疾病的关系.医学分子生物学杂志,2008,5:174-176.
3 Bae SM,Lee CH,Cho YL,et al.Two dimensional gel analysis of protein expression p rofile in squamous cervical cancer patients.Gyncol Oncol,2005,99:26-35.
4 张海燕.AnnexinA2与宫颈癌.中国实用医药,2014,9:253-254.
5 Barua A,Edassery SL,Bitterman P,et al.Prevalence of antitumor antibodies in laying hen model of human ovarian cancer.Int J Gynecol Cancer,2009,19:500-507.
6 Wu B,Zhang F,Yu M,et al.Up-regulation of anxa2 gene promotes proliferation and invasion of breast cancer mcf-7cells.Cell Prolif,2012,V45N3:189-198.
7 Yao H,Zhang Z,Xiao Z,et al.Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gelectrophoresis and laser capture microdissection.Lung Cancer,2009,65:41-48.
8 Pei H,Zhu H,Zeng S,et al.Proteome analysis and tissue microarray for profiling protein markers associateed with lymph node metastasis in colorectal cancer.Proteome Res,2007,6:2495-2501.
9 Tanaka T,Akatsuka S,Ozeki M,et al.Redox regulation of annexinII and its implications for oxidative stress-induced renal carcinogenesis and metastasis.Oncogene,2004,23:3980-3989.
10 Zhao P,Zhang W,Tang J,et al.AnnexinII promotes in vasion and migration of human hepatocellular carcin cells in vitro via its interaction with HAb18G/CD147.Cancer Sci,2010,101:387-395.
11 Karin M,Ben-Neriah Y.Phosphory lation meets ubiquitinatiao:the control of NF-[kappa]B activity.Annu Rev Immunol,2000,18:621-663.
12 严艳,史玉霞,刘铭球,等.子宫内膜样腺癌组织中NF-kBp65的表达.中华肿瘤防治杂志,2006,13:1734-1736.
13 Baud V,KarinM.Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.Nat Rev Drug Discov,2009,8:33-40.
14 Witzel II,Koh LF,Perkins ND.Regulation of cyclinD1 gene expression.Bio chem Soc Trans,2010,38:217-222.
15 刘畅,李金科,陈恒禧,等.核因子κB、肿瘤坏死因子α在宫颈癌变过程中的表达及临床意义.实用妇产科杂志,2012,28:111-104.
16 Lin C,Wang L,Wang H,et al.Tanshinone II A inhibits brest cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.J Cell Biochem,2013,114:2061-2070.
17 Buskens CJ,Van Rees BP,Sivula A,et al.Prognostic significanice of elevated cyclooxygenase-2 expression in patients with adenocarcinoma of the esophagus.Gastroenterology,2002,122:1800-1807.
18 Sclabas GM,Uwagawa T,Schmidt C,et al.Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin.Cancer,2005,103:2485-2490.
19 Amiri KI,Richmond A.Role of nuclear factor-kappa B in melanoma.Cancer Metastasis Rev,2005,24:301-313.
20 Lu G,Maeda H,Reddy SV,et al.Cloning and characterization of the AnnexinII receptor on human marrow stromal cells.J BioChem,2006,281:30542-30550.
21 Takahashi N,Maeda K,Ishihara A,et al.Regulatory mechanism of osteoclastogenesis by RANKL and wnt signals.Front Biosci,2011,16;21-30.
22 Darnay BG,Haridas V,Ni J,et al.Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK).Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.J Biol Chem,1998,273:20551-20555.
23 Matsumoto M,Sudo T,Saito T,et al.Involvement of P38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kB ligand(RANKL).J Biol chem,2000,275:31155-31161.

     (